Kathiresan Sekar

Kathiresan Sekar is listed in filings as Chief Executive Officer at Verve Therapeutics, Inc.. This profile follows SEC Form 4 activity through Sep 24, 2025, including sale activity. Recent filings connect the profile to Verve Therapeutics, Inc. (VERV), RELAY THERAPEUTICS INC (RLAY), and Maze Therapeutics, Inc. (MAZE). The current snapshot covers public activity from Jul 2, 2024 to Sep 24, 2025. Reported amounts are shown as $86.1K to $2.9M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.